Patent · US Active

Extended release venlafaxine formulation

US8668932B2 · kind B2 · utility

0Cited by

28References

14Claims

0Family size

Assignee

Andrx Pharmaceuticals, Inc. · US

Inventors

Manesh Dixit · Sunrise, US
Xiu Xiu Cheng · Pembroke Pines, US
Avinash Nangia · Weston, US
Chin-Ming Chen · Daxi District, TW

Key dates

Filing date	Mar 18, 2011
Grant date	Mar 11, 2014
Priority date	—
Expiry date	Mar 22, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/5047
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A controlled release dosage form of venlafaxine that comprises an immediate release pellet and an extended release pellet.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.